These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 6264367)
1. Immunologic detection of occult primary cancer of the head and neck. Neel HB; Pearson GR; Weiland LH; Taylor WF; Goepfert HH Otolaryngol Head Neck Surg; 1981; 89(2):230-4. PubMed ID: 6264367 [TBL] [Abstract][Full Text] [Related]
2. The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma. Furukawa M; Takimoto T; Morishita K; Komori T; Ishiguro H; Umeda R Auris Nasus Larynx; 1983; 10(1):43-8. PubMed ID: 6311149 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers. Henderson BE; Louie E; Bogdanoff E; Henie W; Alena B; Henie G Cancer Res; 1974 May; 34(5):1207-10. PubMed ID: 4366990 [No Abstract] [Full Text] [Related]
5. Nasopharyngeal carcinoma (NPC). VI. Presence of an EBV nuclear antigen in fresh tumour biopsies. Preliminary results. de Thé G; Ablashi DV; Liabeuf A; Mourali N Biomedicine; 1973 Aug; 19(8):349-52. PubMed ID: 4359467 [No Abstract] [Full Text] [Related]
6. Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups. Neel HB; Pearson GR; Taylor WF Ann Otol Rhinol Laryngol; 1984; 93(5 Pt 1):477-82. PubMed ID: 6093669 [TBL] [Abstract][Full Text] [Related]
7. An immunologic basis for detection of occult primary malignancies of the head and neck. Coates HL; Pearson GR; Neel HB; Weiland LH; Devine KD Cancer; 1978 Mar; 41(3):912-8. PubMed ID: 205337 [TBL] [Abstract][Full Text] [Related]
8. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma]. Amador García JM; Mendoza Montero J; Expósito Hernández J; Salinero Hernández J; Esquivias López-Cuerpo J; Ballesteros García P Acta Otorrinolaringol Esp; 1992; 43(1):31-6. PubMed ID: 1316136 [TBL] [Abstract][Full Text] [Related]
9. Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to EBV serology. Huang DP; Ho HC; Henle W; Henle G; Saw D; Lui M Int J Cancer; 1978 Sep; 22(3):266-74. PubMed ID: 212372 [No Abstract] [Full Text] [Related]
10. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma. Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus detection in neck metastases by polymerase chain reaction. Walter MA; Menarguez-Palanca J; Peiper SC Laryngoscope; 1992 May; 102(5):481-5. PubMed ID: 1315410 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV) antibody in patients treated by radical radiotherapy for head and neck cancer. Halili MR; Spigland I; Foster N; Ghossein NA J Surg Oncol; 1978; 10(5):457-63. PubMed ID: 215844 [TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology. Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480 [TBL] [Abstract][Full Text] [Related]
14. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody. Lynn T; Tu S; Hirayama T; Kawamura A Jpn J Exp Med; 1973 Apr; 43(2):121-33. PubMed ID: 4352111 [No Abstract] [Full Text] [Related]
15. [The involvement of RCAS1 in creating a suppressive tumor microenvironment in patients with pharyngeal squamous cell carcinoma]. Dutsch-Wicherek M; Windorbska W; Jóźwicki W; Kaźmierczak H Otolaryngol Pol; 2012 Sep; 66(4 Suppl):49-59. PubMed ID: 23164108 [TBL] [Abstract][Full Text] [Related]
16. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC). Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561 [TBL] [Abstract][Full Text] [Related]
17. Determination of nonendemic nasopharyngeal carcinoma by in situ hybridization for Epstein-Barr virus EBER1 RNA: sensitivity and specificity in cervical node metastases. Dictor M; Sivén M; Tennvall J; Rambech E Laryngoscope; 1995 Apr; 105(4 Pt 1):407-12. PubMed ID: 7536285 [TBL] [Abstract][Full Text] [Related]
18. Application of Epstein-Barr virus serology to the diagnosis and staging of North American patients with nasopharyngeal carcinoma. Neel HB; Pearson GR; Weiland LH; Taylor WF; Goepfert HH; Pilch BZ; Goodman M; Lanier AP; Huang AT; Hyams VJ; Levine PH; Henle G; Henle W Otolaryngol Head Neck Surg; 1983 Jun; 91(3):255-62. PubMed ID: 6308537 [TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma. Metastasis to the neck from an unknown or undiscovered primary. DeSanto LW; Neel HB Otolaryngol Clin North Am; 1985 Aug; 18(3):505-13. PubMed ID: 2995900 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus antibodies in Sudanese patients with nasopharyngeal carcinoma: a preliminary report. Malik MO; Banatvala J; Hutt MS; Abu-Sin AY; Hidaytallah A; El-Hadi AE J Natl Cancer Inst; 1979 Feb; 62(2):221-4. PubMed ID: 216831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]